These included a reduction in migration and invasion of multiple hepatocellular carcinoma cell lines in the presence of chemerin overexpression and a reversal of this effect with chemerin neutralizing antibodies [77]. The gene discussed is RARRES2; the disease is hepatocellular carcinoma.